<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00150852</url>
  </required_header>
  <id_info>
    <org_study_id>04-012 (med 04-008)</org_study_id>
    <nct_id>NCT00150852</nct_id>
  </id_info>
  <brief_title>Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.</brief_title>
  <official_title>Vancomycin for Prophylaxis of PEG-Related Wound Infection in MRSA-Positive Patients: a Double-Blind, Randomized, Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <brief_summary>
    <textblock>
      The aim of this study is to determine whether vancomycin with cefazoline is superior to
      vancomycin with placebo in preventing gastrostomy-related wound infection in carriers of
      methicillin-resistant staphylococcus aureus (MRSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Percutaneous endoscopic gastrostomy (PEG) provides an enteral route for long-term nutrition
      in patients unable to swallow. Peristomal wound infection occurs in 5 - 30 % of patients.
      Systematic antibiotic prophylaxis by cephalosporins or ampicillin/clavulanic acid has been
      shown to prevent this complication efficiently.

      MRSA-positive patients have been suggested to be at higher risk of PEG-related wound
      infection due to MRSA. However, recommendations about vancomycin-prophylaxis before surgical
      procedures have not been extended to PEG insertion. This might be due to the fact that the
      exact route of contamination is unknown. It is assumed that contamination occurs when
      gastrostomy tubes are passed through the oropharynx. However, oropharyngeal carriage appears
      less frequent than nasopharyngeal or cutaneous carriage. Furthermore, patients who receive
      PEG are particularly vulnerable to vancomycin toxicity because of older age and multiple
      comorbidities.

      The aim of this study is to compare the rate of infectious complications after PEG insertion
      in patients colonized with MRSA who received either standard intravenous antibiotic
      prophylaxis associated with vancomycin or standard prophylaxis with placebo.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2004</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of PEG-site infection at 3, 7, 14, 21 and 28 days post intervention as assessed by a clinical score (Jain score) and swab culture</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional costs and nursing charges (Programme de Recherche en Nursing (PRN) scoring system)</measure>
  </secondary_outcome>
  <enrollment>96</enrollment>
  <condition>Wound Infection</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PEG insertion in a patient with a swab positive for MRSA during the 4 weeks preceding
             PEG insertion

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  No informed consent obtained either from the patient or from his legal representative

          -  Contraindication to the administration of cefazolin or of vancomycin

          -  Systemic administration of antibiotics effective against MRSA during the week prior to
             the procedure

          -  Technique of PEG insertion different from the standard pull technique proposed by the
             physician in charge and the gastroenterologist

          -  Patients requiring antibiotic prophylaxis of endocarditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Vonlaufen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Gastroenterology, University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alain Vonlaufen, MD</last_name>
    <phone>+41 22 372 93 40</phone>
    <email>Alain.Vonlaufen@hcuge.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe De Saussure, MD</last_name>
    <phone>+ 41 22 372 93 40</phone>
    <email>Philippe.deSaussure@hcuge.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire (CHU)</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Agn√®s Plages</last_name>
      <phone>+ 33 476 76 55 97</phone>
      <email>APlages@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Roblin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gian Dorta</last_name>
      <phone>+ 41 21 314 11 11</phone>
      <email>Gian.Dorta@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Gian Dorta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology, University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Vonlaufen, MD</last_name>
      <phone>+ 41 22 372 93 40</phone>
      <email>alain.vonlaufen@hcuge.ch</email>
    </contact>
    <contact_backup>
      <last_name>Philippe De Saussure, MD</last_name>
      <phone>+ 41 22 372 93 40</phone>
      <email>Philippe.DeSaussure@hcuge.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Alain Vonlaufen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>December 28, 2005</last_update_submitted>
  <last_update_submitted_qc>December 28, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2005</last_update_posted>
  <keyword>Gastrostomy</keyword>
  <keyword>Wound infection</keyword>
  <keyword>Antibiotic prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

